Arcutis Reports Interim Results from the P-III (INTEGUMENT-OLE) Trial of Roflumilast for Mild to Moderate Atopic Dermatitis
September 9, 2023
Arcutis Entered into a Collaboration and License Agreement with Huadong for Roflumilast in Greater China and Southeast Asia
August 11, 2023
Arcutis Reports the US FDA Acceptance of NDA for Roflumilast to Treat Seborrheic Dermatitis in Individuals Aged ≥9 Years
April 19, 2023
Arcutis Reports the NDA Submission of Roflumilast to the US FDA for the Treatment of Seborrheic Dermatitis
February 22, 2023
Arcutis Reports P-II Study Results of Roflumilast for the Treatment of Chronic Plaque Psoriasis
January 16, 2023
Arcutis Reports P-III Trial (INTEGUMENT-2) Results of Roflumilast for the Treatment of Atopic Dermatitis in Adults and Children Ag...
December 13, 2022
Back to Home
Incisive News in 3 Shots.
First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
Terms of Service
Copyright © 2023 PharmaShots - All Rights Reserved.